Citius Pharmaceuticals (CTXR) Other Non-Current Assets (2014 - 2026)
Citius Pharmaceuticals' Other Non-Current Assets came in at $98.17 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 3.9% from $102.18 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Other Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Other Non-Current Assets was $102.18 million, unchanged from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 28.8% (FY2020 to FY2025).
- Going back by fiscal year, Other Non-Current Assets was $102.18 million in FY2024 (+48.6%), $68.78 million in FY2023 (unchanged), $68.78 million in FY2022 (unchanged) and $68.78 million in FY2021 (+138.8%).
- The fiscal Q3 2026 figure represents the lowest quarterly Other Non-Current Assets since fiscal Q3 2024.
- Year-over-year, Other Non-Current Assets has declined for three consecutive quarters, with growth averaging 15.1% over the last six quarters.
- The fastest year-over-year change in Other Non-Current Assets over five years came in fiscal Q3 2022 (growth of 139.0%), and the weakest in fiscal Q2 2024 (a decline of 99.9%).
- Business Quant data shows CTXR's Other Non-Current Assets at $100.06 million (Q2 2026), $101.61 million (Q1 2026) and $102.18 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Citius Pharmaceuticals | 10.37 Mn | -23.20 Mn | 1.00 Mn | 98.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.17 Mn |
| Mar 31, 2026 | 100.06 Mn |
| Dec 31, 2025 | 101.61 Mn |
| Sep 30, 2025 | 102.18 Mn |
| Jun 30, 2025 | 102.18 Mn |
| Mar 31, 2025 | 102.18 Mn |
| Dec 31, 2024 | 102.18 Mn |
| Sep 30, 2024 | 102.18 Mn |
| Jun 30, 2024 | 38,062.00 |
| Mar 31, 2024 | 38,062.00 |
| Dec 31, 2023 | 68.78 Mn |
| Sep 30, 2023 | 68.78 Mn |
| Jun 30, 2023 | 68.78 Mn |
| Mar 31, 2023 | 68.78 Mn |
| Dec 31, 2022 | 68.78 Mn |
| Sep 30, 2022 | 68.78 Mn |
| Jun 30, 2022 | 68.78 Mn |
| Mar 31, 2022 | 68.78 Mn |
| Dec 31, 2021 | 68.78 Mn |
| Sep 30, 2021 | 68.78 Mn |
API Access
Citius Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();